We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for TransDigm Group (TDG) in Q1 Earnings?
Read MoreHide Full Article
Transdigm Group Incorporated (TDG - Free Report) is set to report first-quarter fiscal 2020 results on Feb 4, before market open.
In the last reported quarter, the company delivered a positive earnings surprise of 12.37%. Moreover, it surpassed the Zacks Consensus Estimate in the trailing four quarters, delivering positive earnings surprise of 10.63% on average.
Let’s see how things have shaped up prior to this announcement.
Factors at Play
Revenue passenger miles (RPM), a key growth factor boosting Transdigm’s commercial aftermarket sales, witnessed moderate growth during the October-December quarter. An expanded defense budget along with increased geopolitical tensions across the globe, especially in Iran, is expected to have boosted the company’s defense sales in the soon-to-be-reported quarter.
Apart from these organic sales contributions, positive synergies from the Esterline buyout are expected to have contributed to Transdigm Group’s top and bottom lines in the to-be-reported quarter.
The Zacks Consensus Estimate for fiscal first-quarter revenues is pegged at $1,458 million, indicating an improvement of 46.1% from first-quarter fiscal 2019.
Transdigm Group Incorporated Price and EPS Surprise
However, commercial OEM market sales are expected to reflect signs of weakness primarily due to Boeing’s (BA - Free Report) 737 MAX production rate cuts in the to-be-reported quarter results.
Solid revenue growth along with positive contributions from Esterline is expected to have boosted the company’s fiscal first-quarter earnings.
The Zacks Consensus Estimate stands at $4.56 per share, implying 18.4% growth from the year-ago quarter’s reported figure.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for Transdigm Group in the fiscal first quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Here are some defense companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:
Heico Corporation (HEI - Free Report) is expected to release fourth-quarter 2019 results soon. The company has an Earnings ESP of +8.94% and a Zacks Rank #1.
Aerojet Rocketdyne Holdings is expected to release fourth-quarter 2019 results soon. The company has an Earnings ESP of +2.17% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
What's in Store for TransDigm Group (TDG) in Q1 Earnings?
Transdigm Group Incorporated (TDG - Free Report) is set to report first-quarter fiscal 2020 results on Feb 4, before market open.
In the last reported quarter, the company delivered a positive earnings surprise of 12.37%. Moreover, it surpassed the Zacks Consensus Estimate in the trailing four quarters, delivering positive earnings surprise of 10.63% on average.
Let’s see how things have shaped up prior to this announcement.
Factors at Play
Revenue passenger miles (RPM), a key growth factor boosting Transdigm’s commercial aftermarket sales, witnessed moderate growth during the October-December quarter. An expanded defense budget along with increased geopolitical tensions across the globe, especially in Iran, is expected to have boosted the company’s defense sales in the soon-to-be-reported quarter.
Apart from these organic sales contributions, positive synergies from the Esterline buyout are expected to have contributed to Transdigm Group’s top and bottom lines in the to-be-reported quarter.
The Zacks Consensus Estimate for fiscal first-quarter revenues is pegged at $1,458 million, indicating an improvement of 46.1% from first-quarter fiscal 2019.
Transdigm Group Incorporated Price and EPS Surprise
Transdigm Group Incorporated price-eps-surprise | Transdigm Group Incorporated Quote
However, commercial OEM market sales are expected to reflect signs of weakness primarily due to Boeing’s (BA - Free Report) 737 MAX production rate cuts in the to-be-reported quarter results.
Solid revenue growth along with positive contributions from Esterline is expected to have boosted the company’s fiscal first-quarter earnings.
The Zacks Consensus Estimate stands at $4.56 per share, implying 18.4% growth from the year-ago quarter’s reported figure.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for Transdigm Group in the fiscal first quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Transdigm Group has an Earnings ESP of +0.51% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Other Stocks to Consider
Here are some defense companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:
Heico Corporation (HEI - Free Report) is expected to release fourth-quarter 2019 results soon. The company has an Earnings ESP of +8.94% and a Zacks Rank #1.
Aerojet Rocketdyne Holdings is expected to release fourth-quarter 2019 results soon. The company has an Earnings ESP of +2.17% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>